Urine tenofovir concentrations correlate with plasma and relate to tenofovir disoproxil fumarate adherence: A randomized, directly observed pharmacokinetic trial (target study)
© The Author(s) 2019. Background. Direct measurement of tenofovir (TFV) in urine could be an objective measure to monitor adherence to preexposure prophylaxis (PrEP) or TFV-based antiretroviral therapy (ART). Methods. We conducted a 3-arm randomized, pharmacokinetic study of tenofovir disoproxil fum...
Saved in:
Main Authors: | Paul K. Drain, Rachel W. Kubiak, Oraphan Siriprakaisil, Virat Klinbuayaem, Justice Quame-Amaglo, Praornsuda Sukrakanchana, Suriyan Tanasri, Pimpinun Punyati, Wasna Sirirungsi, Ratchada Cressey, Peter Bacchetti, Hideaki Okochi, Jared M. Baeten, Monica Gandhi, Tim R. Cressey |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084271956&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70968 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
by: Tim R. Cressey, et al.
Published: (2020) -
A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: The TARGET study
by: Tim R. Cressey, et al.
Published: (2018) -
A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: The TARGET study
by: Tim R. Cressey, et al.
Published: (2018) -
A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: The TARGET study
by: Cressey T., et al.
Published: (2017) -
Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus
by: Tim R. Cressey, et al.
Published: (2018)